试验雷达 AI | ||
|---|---|---|
临床试验 NCT07489664 (INSPIRE) 针对热应激,妊娠,育龄女性,营养状况目前尚未招募。请查看临床试验雷达卡片视图和 AI 发现工具了解所有详情,或在此提出任何问题。 | ||
一个试验符合筛选条件
卡片视图
Indigenous Nutritional Supplements for Pregnancy to Improve Resilience in Environmental Heat (INSPIRE) 292 孕期 饮食
临床试验详情主要以英语提供。然而,试验雷达 AI可以提供帮助!只需点击“试验详解”即可查看和讨论您选择的语言的试验信息。
临床试验NCT07489664 (INSPIRE)是一项针对热应激,妊娠,育龄女性,营养状况的干预性研究试验,当前状态为尚未招募。试验尚未开始,计划于2026年3月1日开始,预计招募292名患者。该研究由Aga Khan University主导,计划于2028年12月1日完成。试验数据来源于ClinicalTrials.gov,最后更新时间为2026年3月24日。
简要概括
The purpose of this study is to learn whether a simple, traditional, and balanced meal made from local foods, eaten once a day during pregnancy, can help women in rural Pakistan stay healthier in hot weather and give birth to healthier babies. Climate change has made heat a serious challenge for pregnant women, especially in areas with limited resources. This study will explore whether an indigenous meal that is cult...显示更多
详细描述
This study will use a quasi-experimental design to study if the effects of an indigenous heat-mitigating balanced dietary intervention on maternal health and neonatal development when implemented from preconception to delivery in a region with high temperatures.
The study will recruit 292 women of reproductive age who plan to become pregnant and assign them to either the intervention group or the comparison group in...
显示更多官方标题
Indigenous Nutritional Supplements for Pregnancy to Improve Resilience in Environmental Heat
疾病
热应激妊娠育龄女性营养状况出版物
关于此临床试验发表的科学文章和研究论文:其他研究标识符
- INSPIRE
- 10697-33069
- 074884 (其他拨款/资助编号) (Bill & Melinda Gates Foundation)
NCT编号
实际开始日期
2026-03
最近更新发布
2026-03-24
预计完成日期
2028-12
计划入组人数
292
研究类型
干预性研究
试验分期 (阶段)
不适用
试验状态
尚未招募
关键词
Local Food-Based Diet to Improve Birth Outcomes and Heat Resilience in Pregnant Women
maternal depression
placental transcriptomics
microbiome
maternal depression
placental transcriptomics
microbiome
主要目的
预防
分配方式
非随机
干预模型
平行
盲法
双盲
试验组/干预措施
| 参与者组/试验组 | 干预措施/治疗方法 |
|---|---|
其他Indigenous Balanced Diet Arm Participants in this arm will receive minimally modified culturally-tailored indigenous heat-mitigating balanced diet as once a day meal starting from at least one month before conception and throughout the pregnancy till delivery. | Indigenous Balanced Diet Arm The uniqueness of this intervention lies in its culturally-preservative approach, its novel target of heat stress, its timing (preconception), and its integrated process (nutritionist collaboration + overall dietary counseling). It specifically targets heat resilience in pregnancy through a holistic approach of adapting dietary intervention as mitigating strategy for providing resilience to heat stress and evaluating...显示更多 |
无干预Usual Diet Arm Pregnant women in this arm will continue with their usual diet, and receives standard antenatal care. | 不适用 |
主要终点
次要终点
| 结果指标 | 度量标准描述 | 时间框架 |
|---|---|---|
Difference in proportion of neonates with low Weight-for-Gestational-Age Z-score (WGAZ< -2 SD) at birth between intervention and control arms. | Neonatal birth weight (grams) will be measured using a digital infant weighing scale within 24 hours of birth. Birth weight will be converted into WGAZ using WHO 2013 sex- and gestational age-specific reference standards. The percentage of neonates with low WGAZ (\< -2 SD) will be calculated for both supplemented and non-supplemented groups, and comparisons between groups will be made using appropriate statistical methods, adjusting for maternal heat stress exposure.
Unit of Measure: % of neonates with WGAZ \< -2 SD | Within 24 hours of delivery |
Difference in proportion of neonates with low height-for-Gestational-Age Z-score (LGAZ< -2 SD) at birth between intervention and control arms. | Neonatal birth height (cm) will be measured using a standardized neonate's height scale within 24 hours of birth. Birth height will be converted into LGAZ using WHO 2013 sex- and gestational age-specific reference standards. The percentage of neonates with low LGAZ (\< -2 SD) will be calculated for both supplemented and non-supplemented groups, and comparisons between groups will be made using appropriate statistical methods, adjusting for maternal heat stress exposure.
Unit of Measure: % of neonates with LGAZ \< -2 SD | Within 24 hours of delivery |
| 结果指标 | 度量标准描述 | 时间框架 |
|---|---|---|
Gestational age at delivery | Gestational age will be determined based on first-trimester ultrasound and/or last menstrual period (LMP).
Unit of Measure: Weeks | At delivery date |
Mode of delivery | Mode of delivery will be recorded as vaginal or cesarean section. Unit of Measure: Percentage (%) of cesarean deliveries | At delivery |
Maternal serum ferritin concentration | Maternal serum ferritin will be measured using standardized immunoturbidimetric assay on an automated chemistry analyzer.
Unit of Measure: ng/mL | Evaluated at the end of each trimester (within one week before or after the scheduled time point), from enrollment until delivery. |
Maternal serum folate concentration | Maternal serum folate will be measured using standardized laboratory assay on automated immunoassay analyzer. | Evaluated at the end of each trimester (within one week before or after the scheduled time point), from enrollment until delivery. |
Maternal serum 25-hydroxyvitamin D concentration | Maternal serum 25-hydroxyvitamin D concentration will be measured using standardized laboratory assay on automated immunoassay analyzer.
Unit of Measure: ng/mL | Evaluated at the end of each trimester (within one week before or after the scheduled time point), from enrollment until delivery. |
Generalized anxiety symptoms | Maternal mental health will be assessed using a validated psychological questionnaires Generalized Anxiety Disorder-7 (GAD-7) for assessing generalized anxiety symptoms over the past two weeks.
Unit of Measure: The scale comprises 7 items, each rated on a 4-point Likert scale from 0 (not at all) to 3 (almost every day), with a total score ranging from 0 to 21.
Interpretation: A score of 15 or higher is indicative of severe anxiety. | Evaluated at the end of each trimester (within one week before or after the scheduled time point), from enrollment until delivery. |
Maternal gut microbiome alpha diversity | Alpha diversity of maternal gut microbiome will be assessed using 16S rRNA gene sequencing of stool samples.
Unit of Measure: Shannon diversity index | Evaluated at the end of each trimester (within one week before or after the scheduled time point), from enrollment until delivery. |
Placental gene expression levels | Placental gene expression will be quantified using RNA sequencing. Expression levels will be reported as normalized transcript counts.
Unit of Measure: Normalized transcript counts | At delivery |
Estimated fetal weight during pregnancy | Estimated fetal weight will be calculated using ultrasound biometric measurements according to standard obstetric formulas.
Unit of Measure: Grams | Evaluated at the end of each trimester (within one week before or after the scheduled time point), from enrollment until delivery. |
Perceived stress score | Perceived Stress Scale-10 (PSS-10) to assess perceived stress over the past month.
Unit of Measure: The scale consists of 10 items, each rated on a 5-point Likert scale from 0 (never) to 4 (very often), with a total score ranging from 0 to 40.
Interpretation: A score of 27 or higher indicates higher perceived stress. | Assessed at enrollment (baseline), monthly during pregnancy, and postpartum (after 2 weeks of delivery). |
Postnatal depression symptoms | Edinburgh Postnatal Depression Scale (EPDS) to assess postnatal depression symptoms over the past week.
Unit of Measure: The scale comprises 10 items, each rated on a 4-point Likert scale from 0 (no) to 3 (yes), with a total score ranging from 0 to 30.
Interpretation: A score of 13 or greater is indicative of postnatal depression. | Assessed at enrollment (baseline), monthly during pregnancy, and postpartum (after 2 weeks of delivery). |
Depression symptoms | Patient Health Questionnaire-9 (PHQ-9) to assess depression symptoms over the past two weeks.
Unit of Measure: The scale consists of 9 items, each rated on a 4-point Likert scale from 0 (not at all) to 3 (nearly every day), with a total score ranging from 0 to 27.
Interpretation: A score of 10 or greater indicates moderate to severe depression. | Assessed at enrollment (baseline), monthly during pregnancy, and postpartum (after 2 weeks of delivery). |
Combined Depression, Anxiety, and Stress score | Depression, Anxiety, and Stress Scale-21 (DASS-21) to Assesses depression, anxiety, and stress over the past week.
Unit of Measure: The scale consists of 21 items, divided into three subscales, each rated on a 4-point Likert scale from 0 (did not apply to me at all) to 3 (applied to me most of the time). Each subscale score is multiplied by 2 to match the original DASS-42 format.
Interpretation: A score of 14 or greater is indicative of moderate to severe depression, anxiety, and stress. | Assessed at enrollment (baseline), monthly during pregnancy, and postpartum (after 2 weeks of delivery). |
参与助手
资格标准
适龄参与研究
成人
最低年龄要求
18 Years
适龄性别
女性
接受健康志愿者
是
- Women aged 18-45 years belonging to a low to middle socioeconomic status, residing in Mithi, Districts in Sindh.
- Planning to conceive within the study time frame and expect to become pregnant within four months of starting nutritional intervention.
- Women who confirm their pregnancy during the first trimester i.e., before 8 weeks of gestational age.
- Women using long-lasting contraceptives such as IUDs, implants, and injectable methods like Depo-Provera.
- Women with a history of multiple miscarriage or stillbirths.
- Women with known chronic diseases, such as cardiovascular disorders, hepatic disorders, renal disorders, and infectious diseases.
- Women suffering from severe malnutrition (WHO: Underweight i.e., having BMI < 16 Kg/m2 or obese having BMI ≥ 30 Kg/m2).
- Women having severe anemia (WHO: Severe anemia i.e., Hb < 7g/dL).
- Women currently enrolled in BISP supplementation programs or taking any supplements other than iron and folic acid (IFA) will be excluded from the study.
- Those who do not become pregnant within three months of supplementation during pre-conception.
研究责任方
Junaid Iqbal, 主要研究者, Assistant Professor (Research), Department of Paediatrics & Child Health., Aga Khan University
研究中心联系人
联系人: Junaid Iqbal, PhD, +923353189185, [email protected]
联系人: Kehkashan Begum Hussain, MS, +923368906517, [email protected]
1 位于 1 个国家/地区的研究中心
Aga Khan University, Karachi, 74800, Pakistan
Junaid Iqbal, PhD, 联系人, 00922134861648, [email protected]
Kehkashan Begum, MS, 联系人, 00922134864088, [email protected]